These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 7513677
1. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Mondazzi L, Bottelli R, Brambilla G, Rampoldi A, Rezakovic I, Zavaglia C, Alberti A, Idèo G. Hepatology; 1994 May; 19(5):1115-23. PubMed ID: 7513677 [Abstract] [Full Text] [Related]
2. Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival. Grieco A, Marcoccia S, Miele L, Marmiroli L, Caminiti G, Ragazzoni E, Cotroneo AR, Cefaro GA, Rapaccini GL, Gasbarrini G. Hepatogastroenterology; 2003 May; 50(49):207-12. PubMed ID: 12630024 [Abstract] [Full Text] [Related]
3. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan. Kawai S, Tani M, Okamura J, Ogawa M, Ohashi Y, Monden M, Hayashi S, Inoue J, Kawarada Y, Kusano M, Kubo Y, Kuroda C, Sakata Y, Shimamura Y, Jinno K, Takahashi A, Takayasu K, Tamura K, Nagasue N, Nakanishi Y, Makino M, Masuzawa M, Yumoto Y, Mori T, Oda T. Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915 [Abstract] [Full Text] [Related]
4. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M, Yamaoka Y, Liver Cancer Study Group of Japan. Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600 [Abstract] [Full Text] [Related]
13. [Transcatheter arterial chemoembolization technique in cirrhotic patients with hepatocarcinoma. Considerations on the procedure and evaluation of survival]. Roversi R, Milandri GL, Ricci S, Rossi G, Dal Monte PR. Radiol Med; 1994 Dec; 88(6):834-9. PubMed ID: 7878244 [Abstract] [Full Text] [Related]
15. [Prognostic factors for survival following transarterial chemoembolization in advanced hepatocellular carcinoma]. Alvarez R, Bañares R, Echenagusía A, Carneros JA, Santos L, Simó G, Camúñez F. Gastroenterol Hepatol; 2000 Apr; 23(4):153-8. PubMed ID: 10863854 [Abstract] [Full Text] [Related]
16. Needle biopsy of hepatocellular carcinoma: assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes. Group d'Etude et de Traitement du Carcinoma Hépatocellulaire. Chapel F, Guettier C, Chastang C, Rached AA, Mathieu D, Tepper M, Beaugrand M, Trinchet JC. Cancer; 1996 Mar 01; 77(5):864-71. PubMed ID: 8608476 [Abstract] [Full Text] [Related]